Keywords: roche, fuzeon, cleared, switzerland, announced, enfuvirtide, first

Roche's Fuzeon cleared in Switzerland

Article | 02 June 2003

Print This

Roche has announced that Fuzeon (enfuvirtide), the first in a novel class of HIV entry inhibitors, has been granted marketing ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in